Wouter Boon
Wouter Boon
Innovation Studies Groups, Utrecht University
Geverifieerd e-mailadres voor uu.nl - Homepage
Titel
Geciteerd door
Geciteerd door
Jaar
Social impacts of transport: literature review and the state of the practice of transport appraisal in the Netherlands and the United Kingdom
KT Geurs, W Boon, B Van Wee
Transport reviews 29 (1), 69-90, 2009
2302009
Towards a typology of intermediaries in sustainability transitions: A systematic review and a research agenda
P Kivimaa, W Boon, S Hyysalo, L Klerkx
Research Policy 48 (4), 1062-1075, 2019
1372019
Demand articulation in emerging technologies: intermediary user organisations as co-producers?
WPC Boon, EHM Moors, S Kuhlmann, REHM Smits
Research Policy 40 (2), 242-252, 2011
1182011
Demand, challenges, and innovation. Making sense of new trends in innovation policy
W Boon, J Edler
Science and Public Policy 45 (4), 435-447, 2018
852018
Demand articulation in intermediary organisations: The case of orphan drugs in the Netherlands
WPC Boon, EHM Moors, S Kuhlmann, REHM Smits
Technological forecasting and social change 75 (5), 644-671, 2008
792008
The role of users in innovation in the pharmaceutical industry
REHM Smits, WPC Boon
Drug discovery today 13 (7-8), 353-359, 2008
762008
Exploring emerging technologies using metaphors–a study of orphan drugs and pharmacogenomics
W Boon, E Moors
Social science & medicine 66 (9), 1915-1927, 2008
712008
Carsharing business models in Germany: characteristics, success and future prospects
K Münzel, W Boon, K Frenken, T Vaskelainen
Information Systems and e-Business Management 16 (2), 271-291, 2018
622018
Stakeholder interaction within research consortia on emerging technologies: Learning how and what?
A Roelofsen, WPC Boon, RR Kloet, JEW Broerse
Research Policy 40 (3), 341-354, 2011
562011
User-led innovation in civic energy communities
GW de Vries, WPC Boon, A Peine
Environmental Innovation and Societal Transitions 19, 51-65, 2016
532016
Conditional approval and approval under exceptional circumstances as regulatory instruments for stimulating responsible drug innovation in Europe
WPC Boon, EHM Moors, A Meijer, H Schellekens
Clinical Pharmacology & Therapeutics 88 (6), 848-853, 2010
532010
Exploring dynamics and strategies of niche protection
WPC Boon, EHM Moors, AJ Meijer
Research Policy 43 (4), 792-803, 2014
482014
Use of the conditional marketing authorization pathway for oncology medicines in Europe
J Hoekman, WPC Boon, JC Bouvy, HC Ebbers, JP de Jong, ML De Bruin
Clinical Pharmacology & Therapeutics 98 (5), 534-541, 2015
442015
Balancing divergence and convergence in transdisciplinary research teams
WPC Boon, MMH Chappin, J Perenboom
Environmental science & policy 40, 57-68, 2014
422014
Passing the baton: How intermediaries advance sustainability transitions in different phases
P Kivimaa, S Hyysalo, W Boon, L Klerkx, M Martiskainen, J Schot
Environmental Innovation and Societal Transitions 31, 110-125, 2019
412019
Influence of 3D printing on transport: a theory and experts judgment based conceptual model
W Boon, B Van Wee
Transport Reviews 38 (5), 556-575, 2018
372018
The role of patient advocacy organisations in neuromuscular disease R&D–The case of the Dutch neuromuscular disease association VSN
W Boon, R Broekgaarden
Neuromuscular disorders 20 (2), 148-151, 2010
342010
User-producer interactions in emerging pharmaceutical and food innovations
EHM Moors, WPC Boon, R Nahuis, RLJ Vandeberg
International journal of innovation management 12 (03), 459-487, 2008
302008
Institutional entrepreneurship in the platform economy: How Uber tried (and failed) to change the Dutch taxi law
P Pelzer, K Frenken, W Boon
Environmental Innovation and Societal Transitions 33, 1-12, 2019
262019
Learning to shield–Policy learning in socio-technical transitions
WPC Boon, S Bakker
Environmental Innovation and Societal Transitions 18, 181-200, 2016
262016
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20